Indaptus Therapeutics, Inc.
INDP· Nasdaq
Released Aug 16, 2021, after the close
10-Q filed Aug 16, 2021, 47 days after period end · 0001493152-21-020172
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Net Income | -$515.48K | -$712.62K |
| EPS Diluted | -$5.53 | -$3.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Indaptus Therapeutics, Inc. · CIK 1857044 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end
2.1% from the close of Aug 16, 2021 to the close of Aug 17, 2021, the first after the release.